Image-Guided Radiation Therapy Market

The global image-guided radiation therapy market is projected to reach USD 2.4 billion by 2028 from USD 1.9 billion in 2023, growing at a CAGR of 5.2% during the forecast period. Cancers, such as head and neck cancer, prostate cancer, lung cancer, and breast cancer diseases, are on the rise globally. Image-guided radiation therapy is extensively used in non-invasive cancer treatments, including radiation therapy, to treat these conditions. The growing burden of cancer is driving the demand for image-guided radiation therapy. Increasing awareness and availability of non-invasive treatments, rising demand for image-guided radiation therapy, and Increasing government initiatives to manage cancerous diseases in healthcare are a few drivers that collectively contribute to the growth of the image-guided radiation therapy market, and as healthcare technologies continue to evolve, the demand for image-guided radiation therapy is expected to rise further in the coming years. However, higher initial investment cost limits the entry of new participants and market growth.

The image-guided radiation therapy market is highly competitive, with several established players and new entrants vying for market share. The competition in the image-guided radiation therapy market is driven by factors such as technological advancements, product innovation, pricing strategies, distribution networks, and regulatory compliance. Here are some of the key players in the image-guided radiation therapy market. Siemens Healthineers AG (Germany), Hitachi (Japan), Koninklijke Philips (Netherlands), Elekta (Sweden), Viewray Technology Inc. (US), Accuray Incorporated (US), and GE Healthcare Company (US).

To know about the assumptions considered for the study download the pdf brochure

Siemens Healthineers AG (Germany): Siemens Healthineers AG is a prominent player in the image-guided radiation therapy market and has a significant presence in this segment. The company offers a range of image-guided radiation therapy designed for various cancer treatments, including prostate cancer, lung, and breast cancer. The company acquired Varian Medical Systems, which strengthens Siemens Healthineers' position in the radiotherapy and oncology market.

Siemens Healthineers' image-guided radiation therapy portfolio includes products such as:

ARTIS (Family): Image-guided radiation therapy encompasses an extensive array of interventional ARTIS angiography systems, presenting holistic solutions across clinical domains encompassing interventional radiology, interventional cardiology, electrophysiology, and surgical applications.

Nexaris MR (family): Integrating cutting-edge MRI technology from MAGNETOM Sola and MAGNETOM Vida with advanced operating room (OR) solutions, it yields exceptional image precision, secure and streamlined patient preparation and transfer, while also offering cost-efficient and adaptable options for facility layout and OR tables.

Cios Select (family): Engineered to optimize image intensifier technology of the highest caliber, further enriched by intelligent image quality and dose algorithms, a wireless footswitch, and advanced cybersecurity features. This culminates in a platform that achieves exceptional image clarity, effortless operability, and superior system reliability.

Siemens Healthineers’ image-guided radiation therapy is known for its advanced imaging technologies to provide clinicians with detailed images that help in planning and delivering precise radiation treatments by offering state-of-the-art image-guided radiation therapy systems.

The company's strong presence in the image-guided radiation therapy market can be attributed to its commitment to innovation, extensive research and development efforts, and strategic acquisitions of companies specializing in non-invasive medical procedures. Siemens Healhineers’ comprehensive image-guided radiation therapy portfolio, combined with its global distribution network and strong brand reputation, positions it as a leading player in the image-guided radiation therapy market.

GE Healthcare Company (US): GE Healthcare Company is another major player in the image-guided radiation therapy market, offering a wide range of radiation therapy for various non-invasive procedures. The company's IGRT portfolio includes products designed for interventional guided systems, surgical imaging, and computed tomography.

GE Healthcare company’s IGRT is known for its advanced features, including low dose with enhancements for an easy and efficient experience. The company focuses on incorporating innovative technologies and materials into its imaging technology to improve procedural outcomes and patient care.

GE Healthcare Company’s strong presence in the image-guided radiation therapy market can be attributed to its extensive research and development efforts, strategic acquisitions, and collaborations with leading physicians and medical institutions. The company's broad portfolio of radiation therapy, along with its global distribution network and strong brand recognition, positions it as a key player in the image-guided radiation therapy market.

Elekta (Sweden): Elekta is a well-known and established player in the image-guided radiation therapy market; the company is a pioneer in precision radiation medicine and is involved in developing treatment solutions. The company's image-guided radiation therapy portfolio encompasses products designed for radiation therapy and other non-invasive procedures.

Elekta’s IGRT products are known for their advanced image-guided radiation therapy (IGRT) and innovative features that enhance deliverability and visibility under imaging guidance. The company's focus on continuous innovation and collaboration with healthcare professionals contributes to the development of cutting-edge image-guided radiation therapy that addresses specific clinical needs.

Elekta’s strong presence in the image-guided radiation therapy market can be attributed to its extensive expertise in radiation medicine, commitment to research and development, and global distribution network. The company's comprehensive image-guided radiation therapy portfolio and dedication to providing high-quality products have established it as a significant player in the microcatheter market.

Related Reports:

Image-Guided Radiation Therapy Market by Product (4D RT, LINAC, MRI-guided radiotherapy, Portal CT Imaging), Procedure (IMRT, Stereotactic, Particle), Application (Neck, Prostate, Breast cancer), Enduser (Hospital, ACC) & Region - Global Forecasts to 2028

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]